Exosites: Their current status, and their relevance to the duration of action of long-acting β2-adrenoceptor agonists

Trends in Pharmacological Sciences

Volumn 17, Issue 9, 1996, Pages 324-330

  Coleman, Robert A ^a   Johnson, Malcolm ^b   Nials, Anthony T ^c   Vardey, Christopher J ^b  

^a Pharmagene Laboratories Ltd   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Glaxo Wellcome Medicines Res Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 HYDROXYPHENYL) 2 [3 (2 METHOXYPHENYL) 1,1 DIMETHYLPROPYLAMINO]ETHANOL; BAMBUTEROL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARMOTEROL; CGP 59162; CLENBUTEROL; CYCLIC AMP; FORMOTEROL; GR 31354; GR 35795; ISOPRENALINE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; RP 58802B; SALBUTAMOL; SALMETEROL; UNCLASSIFIED DRUG;

BINDING SITE; BRONCHODILATING ACTIVITY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HUMAN; KINETICS; LIPID SOLUBILITY; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; THEORY;

EID: 0030247623     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)10040-7     Document Type: Review

References (52)

1. 1 Lands, A. M., Luduena, F. P. and Buzzo, H. J. (1967) Life Sci. 6, 2241-2249
2. 2 Cullum, V. A., Farmer, J. B., Jack, D. and Levy, G. P. (1968) Br. J. Pharmacol. 35, 141-151
3. 3 Boulet L. P. (1994) Drugs 47, 207-222
4. 4 Löfdahl, C-G. and Svedmyr, N. (1984) Allergy 39, 485-489
5. 5 Underwood, S. L., Lewis, S. A. and Raeburn, D. (1992) Pulm. Pharmacol. 5, 203-212
6. 6 Voss, H. P., Donnell, D. and Bast, A. (1992) Eur. J. Pharmacol. 227, 403-409
7. 7 Olsson, O. A. T. and Svensson, L. Å. (1984) Pharm. Res. 1, 19-23
8. 8 Ullman, A. and Svedmyr, N. (1988) Thorax 43, 674-678
9. 9 Löfdahl, C-G. and Svedmyr, N. (1986) Acta Pharmacol. Toxicol. 229, A1358
10. 10 Engelhardt, G. (1972) Arzneim.-Forsch. Drug Res. 22, 869-876
11. 11 Svensson, L. Å. (1994) Adv. Drug Deliv. Rev. 14, 319-330
12. 12 Coleman, R. A., Johnson, M., Nials, A. T. and Sumner, M. J. (1990) Br. J. Pharmacol. 99, 121P
13. 13 Nials, A. T., Butchers, P. R., Coleman, R. A., Johnson, M. and Vardey, C. J. (1990) Br. J. Pharmacol. 99, 120P
14. 14 Nials, A. T. et al. (1994) Eur. J. Pharmacol. 251, 127-135
15. 15 Anderson, G. P. (1991) in New Drugs for Asthma Therapy. Agents and Actions Supplement (Vol. 34) (Anderson, G. P., Chapman, I. D. and Morley, J., eds), pp. 97-115, Birkhauser Verlag
16. 16 Bremner, P. et al. (1993) Eur. Resp. J. 6, 204-210
17. 17 Ball, D. I. et al. (1991) Br. J. Pharmacol. 104, 665-671
18. 18 Kenakin, T. (1987) in Pharmacological Analysis of Drug Receptor Interaction (Kenakin, T. P., ed.), pp. 205-244, Raven Press
19. 19 Standifer, K. M., Pitha, J. and Baker, S. P. (1989) Naunyn-Schmiedeberg's Arch. Pharmacol. 339, 129-137
20. 20 Rhodes, D. G., Newton, R., Butler, R. and Herbette, L. (1992) Mol. Pharmacol. 42, 596-602
21. 21 Bradshaw, J. et al. (1987) Br. J. Pharmacol. 92, 590P
22. 22 Rocha e Silva, M. (1969) Eur. J. Pharmacol. 6, 294-302
23. 23 Jack, D. (1991) Br. J. Clin. Pharmacol. 31, 501-514
24. 24 Green, S. A., Spasoff, A. P., Coleman, R. A., Johnson, M. and Liggett, S. B. (1996) J. Biol. Chem. 271, 24029-24035
25. 25 Nials, A. T. et al. (1994) Eur. J. Pharmacol. 251, 127-135
26. 26 Jeppsson, A-B., Kallström, B-L. and Waldeck, B. (1992) Pharmacol. Toxicol. 71, 272-277
27. 27 Nials, A. T., Coleman, R. A., Johnson, M. and Vardey, C. J. (1994) Am. Rev. Resp. Dis. 149, A481
28. 28 Butchers, P. R., Vardey, C. J. and Johnson, M. (1991) Br. J. Pharmacol. 104, 672-676
29. 29 Naline, E. et al. (1994) Eur. Resp. J. 7, 914-920
30. 30 Nials, A. T. et al. (1993) Br. J. Pharmacol. 110, 1112-1116
31. 31 Nials, A. T., Sumner, M. J., Johnson, M. and Coleman, R. A. (1993) Br. J. Pharmacol. 108, 507-515
32. 32 Jeppsson, A. B., Löfdahl, C-G., Waldeck, B. and Widmark, E. (1989) Pulm. Pharmacol. 2, 81-85
33. 33 Löfdahl, C-G. (1990) Lung (Suppl.) 168, 18-22
34. 34 Nials, A. T. and Coleman, R. A. (1992) Am. Rev. Resp. Dis. (Suppl.) 145, A391
35. 35 Bergendal, A., Anderson, G. P., Linden, A., Skoogh, B-E. and Lofdahl, C-G. (1995) Eur. Resp. J. 8, 454S
36. 36 McCrea, K. E. and Hill, S. J. (1993) Br. J. Pharmacol. 110, 619-626
37. 37 Clark, R. B., Allal, C., Friedman, J., Johnson, M. and Barber, R. (1996) Mol. Pharmacol. 49, 182-189
38. 38 Wallis, C. J. (1993) Actual. Chim. Ther. 20é serie, 265-292
39. 39 Anderson, G. P., Lindén, A. and Rabe, K. F. (1994) Eur. Resp. J. 7, 569-578
40. 40 Johnson, M. et al. (1993) Life Sci. 52, 2131-2143
41. 41 Coleman, R. A. and Nials, A. T. (1989) J. Pharmacol. Methods 21, 71-86
42. 42 Kalish, L. B., Blaiss, M. S. and Lima, J. J. (1993) Ann. Allerg. 72, 58
43. 43 Johnson, M. and Coleman, R. A. (1995) in Asthma and Rhinitis (Busse, W. W. and Holgate, S. T., eds), pp. 1278-1295, Blackwell Scientific Publications
44. 44 Baker, A. J. and Fuller, R. W. (1990) Am. Rev. Resp. Dis. 141, A394
45. 45 Vardey, C. J., Nials, A. T. and Coleman, R. A. (1994) Am. Rev. Resp. Dis. 149, A361
46. 46 Nials, A. T., Barker, R. C., Coleman, R. A. and Vardey, C. J. (1994) Am. Rev. Resp. Dis. 149, A482
47. 47 Bergendal, A., Lindén, A., Lötvall, J., Skoogh, B-E. and Löfdahl, C-G. (1992) Am. Rev. Resp. Dis. 45, A393
48. 48 Coleman, R. A., Nials, A. T., Johnson, M. and Vardey, C. J. (1994) Am. Rev. Resp. Dis. 149, A484
49. 49 Anderson, G. P. (1992) in Formoterol: Fast and Long-lasting Bronchodilatation (Holgate, S. T., ed.), pp. 3-11, Royal Society of Medicine Services International Congress and Symposium Series, 194
50. 50 Van Noord, J. A. et al. (1994) Eur. Resp. J. 7, 111S
51. 51 Jeppsson, A. B., Nilsson, E. and Waldeck, B. (1994) Eur. J. Pharmacol. 257, 137-143
52. 52 Johnson, M. (1995) Medicinal Research Reviews (Vol. 15) (de Stevens, G., ed.), pp. 225-257